Cargando…

Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A(2A) Adenosine Receptor Useful in Neurodegenerative Disorders

Currently, the number of patients with neurodegenerative pathologies is estimated at over one million, with consequences also on the economic level. Several factors contribute to their development, including overexpression of A(2A) adenosine receptors (A(2A)AR) in microglial cells and up-regulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francucci, Beatrice, Angeloni, Simone, Dal Ben, Diego, Lambertucci, Catia, Ricciutelli, Massimo, Spinaci, Andrea, Smirnov, Aleksei, Volpini, Rosaria, Buccioni, Michela, Marucci, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302146/ https://www.ncbi.nlm.nih.gov/pubmed/37375315 http://dx.doi.org/10.3390/molecules28124762

Ejemplares similares

“Dual Anta-Inhibitors” of the A(2A) Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
por: Spinaci, Andrea, et al.
Publicado: (2023)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
por: Dal Ben, Diego, et al.
Publicado: (2019)

P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications
por: Spinaci, Andrea, et al.
Publicado: (2021)

Combined Therapy of A(1)AR Agonists and A(2A)AR Antagonists in Neuroinflammation
por: Marucci, Gabriella, et al.
Publicado: (2021)

Adenosine Receptors as Neuroinflammation Modulators: Role of A(1) Agonists and A(2A) Antagonists
por: Martí Navia, Aleix, et al.
Publicado: (2020)

A(2A) Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
por: Spinaci, Andrea, et al.
Publicado: (2022)

Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A(2B) adenosine receptor
por: Dal Ben, Diego, et al.
Publicado: (2013)

The possible role of the nucleoside adenosine in countering skin aging: A review
por: Marucci, Gabriella, et al.
Publicado: (2022)

The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A(3) Receptor Agonist, in a Rat Model of Colitis
por: Antonioli, Luca, et al.
Publicado: (2020)

Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A(1) Receptor Ligands
por: Zuccarini, Mariachiara, et al.
Publicado: (2021)

Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines
por: Buccioni, Michela, et al.
Publicado: (2014)

Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligands
por: Dal Ben, Diego, et al.
Publicado: (2006)

Erratum to: Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligands
por: Dal Ben, Diego, et al.
Publicado: (2006)

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A(1) and A(2A) Receptors, and Efficacy in Animal Models of Depression
por: Varano, Flavia, et al.
Publicado: (2021)

Mucosal‐sparing augmented non‐transected anastomotic (MsANTA) urethroplasty: a step forward in ANTA urethroplasty
por: Joshi, Pankaj, et al.
Publicado: (2022)

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile
por: Lambertucci, Catia, et al.
Publicado: (2007)

2- and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors
por: Volpini, Rosaria, et al.
Publicado: (2005)

antaRNA: ant colony-based RNA sequence design
por: Kleinkauf, Robert, et al.
Publicado: (2015)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
por: Dal Ben, Diego, et al.
Publicado: (2018)

Synthesis and Ability of New Ligands for G Protein-Coupled Receptors 17 (GPR17)
por: Zhuo, Tongyou, et al.
Publicado: (2017)

Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A(2A) adenosine receptor binding site
por: Matricon, Pierre, et al.
Publicado: (2017)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Regulation of antimycin biosynthesis by the orphan ECF RNA polymerase sigma factor σ(AntA)
por: Seipke, Ryan F., et al.
Publicado: (2014)

antaRNA – Multi-objective inverse folding of pseudoknot RNA using ant-colony optimization
por: Kleinkauf, Robert, et al.
Publicado: (2015)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP
por: Roth, Aileen, et al.
Publicado: (2021)

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
por: Burger, Karen L., et al.
Publicado: (2023)

Geospatial analysis of the associations between environmental contamination with livestock feces and children with chronic fascioliasis in the Anta province of Cusco, Peru
por: Tanabe, Melinda Barbara, et al.
Publicado: (2022)

Structure and Spatial Distribution of the Chironomidae Community in Mesohabitats in a First Order Stream at the Poço D'Anta Municipal Biological Reserve in Brazil
por: Vescovi Rosa, Beatriz Figueiraujo Jabour, et al.
Publicado: (2011)

CK1δ Kinase Activity Is Modulated by Chk1-Mediated Phosphorylation
por: Bischof, Joachim, et al.
Publicado: (2013)

CK1δ as a potential therapeutic target to treat bladder cancer
por: Lin, Yu-Chen, et al.
Publicado: (2020)

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
por: Roth, Aileen, et al.
Publicado: (2022)

Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1δ and CK1ε
por: Bischof, Joachim, et al.
Publicado: (2011)

CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch
por: Narasimamurthy, Rajesh, et al.
Publicado: (2018)

The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer
por: Wang, Zhongyuan, et al.
Publicado: (2021)

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists
por: Catarzi, Daniela, et al.
Publicado: (2019)

Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity
por: Cunningham, Peter S., et al.
Publicado: (2016)

Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as neuroprotective agents
por: Joshi, Kopal, et al.
Publicado: (2016)

Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson’s Disease
por: Morales-Garcia, José A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8endufbsv387iirmdibprqucbj